Literature DB >> 9688123

Age dependency of resistance to cerebrospinal fluid outflow.

M J Albeck1, C Skak, P R Nielsen, K S Olsen, S E Børgesen, F Gjerris.   

Abstract

OBJECT: Resistance to cerebrospinal fluid (CSF) outflow (Rout)is an important parameter in assessing the need for CSF shunt placement in patients with hydrocephalus. The normal lower limit of Rout has been estimated on the basis of the clinical effect of shunt placement in patients with varying values of Rout and in young healthy volunteers. The lack of clinical effect from CSF shunts in some elderly patients, despite elevated Rout,suggests that the normal value of Rout increases with age and may be higher in elderly persons. The aim of the present study was to examine the relationship between Rout and age in patients without known CSF dynamic disturbances.
METHOD: Fifty-two patients ranging from 20 to 88 years of age and with no known CSF dynamic disorders were examined. The Rout was measured using a lumbar computerized infusion test. The correlation between Rout and age was analyzed by performing linear regression. The Rout increased significantly with patient age. The Rout in a patient in the eighth decade will be approximately 5 mm Hg/ml/minute higher than in a young patient.
CONCLUSIONS: The present study shows a small but critical increase in Rout with increased patient age. A notable residual variation was present and borderline values of Rout should be regarded and used with caution.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9688123     DOI: 10.3171/jns.1998.89.2.0275

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  23 in total

1.  Outcomes of endoscopic third ventriculostomy in adults.

Authors:  Sandi Lam; Dominic A Harris; Yimo Lin; Brandon G Rocque; Sandra Ham; I-Wen Pan
Journal:  J Clin Neurosci       Date:  2016-07-06       Impact factor: 1.961

2.  Idiopathic normal-pressure hydrocephalus: clinical comorbidity correlated with cerebral biopsy findings and outcome of cerebrospinal fluid shunting.

Authors:  R Bech-Azeddine; P Høgh; M Juhler; F Gjerris; G Waldemar
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-09-29       Impact factor: 10.154

3.  Interaction between ventricular expansion and structural changes in the corpus callosum and putamen in males with FMR1 normal and premutation alleles.

Authors:  Jun Yi Wang; David Hessl; Flora Tassone; Kyoungmi Kim; Randi J Hagerman; Susan M Rivera
Journal:  Neurobiol Aging       Date:  2019-09-24       Impact factor: 4.673

4.  Shunting to the cranial venous sinus using the SinuShunt.

Authors:  Svend Erik Børgesen; Antonio Pieri; Johann Cappelen; Niels Agerlin; Flemming Gjerris
Journal:  Childs Nerv Syst       Date:  2004-05-01       Impact factor: 1.475

Review 5.  The role of cerebrospinal fluid pressure in glaucoma and other ophthalmic diseases: A review.

Authors:  David Fleischman; R Rand Allingham
Journal:  Saudi J Ophthalmol       Date:  2013-03-17

Review 6.  Regulation of cerebrospinal fluid (CSF) flow in neurodegenerative, neurovascular and neuroinflammatory disease.

Authors:  Matthew J Simon; Jeffrey J Iliff
Journal:  Biochim Biophys Acta       Date:  2015-10-22

Review 7.  Monitoring and interpretation of intracranial pressure.

Authors:  M Czosnyka; J D Pickard
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-06       Impact factor: 10.154

Review 8.  Fluid transport in the brain.

Authors:  Martin Kaag Rasmussen; Humberto Mestre; Maiken Nedergaard
Journal:  Physiol Rev       Date:  2021-05-05       Impact factor: 37.312

9.  Anatomical basis and physiological role of cerebrospinal fluid transport through the murine cribriform plate.

Authors:  Jordan N Norwood; Qingguang Zhang; David Card; Amanda Craine; Timothy M Ryan; Patrick J Drew
Journal:  Elife       Date:  2019-05-07       Impact factor: 8.713

10.  Cerebrospinal fluid pressure decreases with older age.

Authors:  David Fleischman; John P Berdahl; Jana Zaydlarova; Sandra Stinnett; Michael P Fautsch; R Rand Allingham
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.